Catalyst Wire Dossier Catalyst Wire Dossier

Effivia

bevacizumab biosimilar · Laboratorios Liomont
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Effivia, covering 2024-10-10 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Effivia®, a Bevacizumab Biosimilar

See pricing